- Home
- MDT vs DHR Comparison
MDT vs DHR Comparison
Compare MDT & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDT | DHR |
|---|---|---|
| Founded | 1949 | 1969 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.3B | 123.6B |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MDT | DHR |
|---|---|---|
| Price | $80.46 | $188.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 13 |
| Target Price | $108.21 | ★ $241.69 |
| AVG Volume (30 Days) | ★ 11.0M | 3.5M |
| Earning Date | 06-03-2026 | 04-21-2026 |
| Dividend Yield | ★ 3.58% | 0.89% |
| EPS Growth | ★ 3.32 | N/A |
| EPS | ★ 3.73 | 1.45 |
| Revenue | ★ $36,364,000,000.00 | $19,893,000,000.00 |
| Revenue This Year | $8.91 | $5.43 |
| Revenue Next Year | $6.54 | $5.74 |
| P/E Ratio | ★ $21.61 | $123.50 |
| Revenue Growth | 8.43 | ★ 8.53 |
| 52 Week Low | $73.31 | $160.93 |
| 52 Week High | $106.33 | $242.80 |
Technical Indicators
Market Signals| Indicator | MDT | DHR |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 61.54 |
| Support Level | $73.85 | $186.78 |
| Resistance Level | $82.83 | $189.21 |
| Average True Range (ATR) | 1.70 | 4.91 |
| MACD | 0.19 | 0.23 |
| Stochastic Oscillator | 52.50 | 91.12 |
Price Performance
Historical ComparisonAbout MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
About DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.